Resumen
L-Asparaginase (ASNase) is used in medicine for neoplasms treatment and in food industry for mitigation of acrylamide in high-temperature processed food. In medicine, commercial ASNases have exhibited side effects and l-glutaminase (GLNase) activity affecting the clinical treatment. The aim of this work was to study a novel ASNase from Enterobacter sp. M55 isolated from Maras Salters in Peru, which was purified and biochemically characterised. This ASNase exhibited a Km of 5.71 mM and a Vmax of 0.16 µmol mL–1 min–1, as well as an optimum temperature and pH of 37 °C and 6, respectively. Moreover, a good activity (80 %) was observed at physiological pH. Likewise, the enzyme increased its activity by around 50% in presence of urea, glutathione, and glucose. Whilst in presence of serum compounds, it kept more that 60 % of activity. In addition, this ASNase showed low GLNase activity.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 167-173 |
Número de páginas | 7 |
Publicación | Chemical and Biochemical Engineering Quarterly |
Volumen | 36 |
N.º | 2 |
DOI | |
Estado | Publicada - 2022 |
Nota bibliográfica
Publisher Copyright:© 2022 Assoc. of Chemists and Chemical Engineers of Croatia. All rights reserved.